RaQualia Pharma Balance Sheet Health
Financial Health criteria checks 3/6
RaQualia Pharma has a total shareholder equity of ¥5.6B and total debt of ¥3.3B, which brings its debt-to-equity ratio to 58.5%. Its total assets and total liabilities are ¥9.8B and ¥4.1B respectively.
Key information
58.5%
Debt to equity ratio
JP¥3.29b
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥3.20b |
| Equity | JP¥5.63b |
| Total liabilities | JP¥4.12b |
| Total assets | JP¥9.75b |
Recent financial health updates
Companies Like RaQualia Pharma (TYO:4579) Can Afford To Invest In Growth
Apr 02
Companies Like RaQualia Pharma (TYO:4579) Can Afford To Invest In Growth
Dec 17Recent updates
Market Participants Recognise RaQualia Pharma Inc.'s (TSE:4579) Revenues Pushing Shares 27% Higher
Sep 04With RaQualia Pharma Inc. (TSE:4579) It Looks Like You'll Get What You Pay For
Jul 17Companies Like RaQualia Pharma (TYO:4579) Can Afford To Invest In Growth
Apr 02The RaQualia Pharma (TYO:4579) Share Price Has Soared 410%, Delighting Many Shareholders
Feb 08
Companies Like RaQualia Pharma (TYO:4579) Can Afford To Invest In Growth
Dec 17Financial Position Analysis
Short Term Liabilities: 4579's short term assets (¥4.3B) exceed its short term liabilities (¥1.0B).
Long Term Liabilities: 4579's short term assets (¥4.3B) exceed its long term liabilities (¥3.1B).
Debt to Equity History and Analysis
Debt Level: 4579's net debt to equity ratio (1.6%) is considered satisfactory.
Reducing Debt: 4579's debt to equity ratio has increased from 0% to 58.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 4579 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 4579 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.